A mini-panel of semi-synthetic analogs of the Amaryllidaceae alkaloid lycorine was screened for cytochrome P450 3A4 (CYP3A4) inhibitory activity, the most potent of which exhibited inhibition as low as 0.21 μM. Elements of this novel pharmacophore unravelled include bulky lipophilic substitution at C2 in conjunction with a small hydrogen bond donor/acceptor at C1, or bulky electron-rich substitution at C1 in conjunction with a vicinal hydrogen bond donor/acceptor.
BastidaJ, LavillaR, ViladomatF. (2006) Chemical and biological aspects of Narcissus alkaloids. In: The Alkaloids, ed. CordellGA, Elsevier, Amsterdam, vol. 63, pp. 87–179.
ViladomatF, BastidaJ, CodinaC, NairJJ, CampbellWE. (1997) Alkaloids of the South African Amaryllidaceae. In: Recent Research Developments in Phytochemistry, Research Signpost Pub., Trivandrum, vol. 1, pp. 131–171;
HoughtonPJ, RenY, HowesMJ. (2006) Acetylcholinesterase inhibitors from plants and fungi. Natural Product Reports, 23, 181–199.
6.
TramNTM, TitorenkovaTV, BankovaVS, HandjievaNV, PopovSS. (2002) Crinum L. (Amaryllidaceae); a Review. Fitoterapia, 73, 183–208;
7.
LikhitwitayawuidK, AngerhoferCK, ChaiH, PezzutoJM, CordellGA, RuangrungsiN. (1993) Cytotoxic and antimalarial alkaloids from the bulbs of Crinum amabile. Journal of Natural Products, 56, 1331–1338.
8.
McNultyJ, NairJJ, CodinaC, BastidaJ, PandeyS, GerasimoffJ, GriffinC. (2007) Selective apoptosis-inducing activity of Crinum type Amaryllidaceae Alkaloids. Phytochemistry, 68, 1068–1074;
9.
McNultyJ, NairJJ, BastidaJ, PandeyS, GriffinC. (2009) Structure-activity studies on the crinane alkaloid apoptosis-inducing pharmacophore. Natural Product Communications, 4, 483–488.
10.
HwangYC, ChuJJH, YangPL, ChenW, YatesMV. (2008) Rapid identification of inhibitors that interfere with poiliovirus replication using a cell-based assay. Antiviral Research, 77, 232–236;
11.
DengL, DaiP, CiroA, SmeeDF, DjaballahH, ShumanS, (2007) Identification of novel antipoxviral agents: mitoxantrone inhibits Vaccinia virus replication by blocking virion assembly. Journal of Virology, 81, 13392–13402;
12.
LiR, TanX, (2005) Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Research, 67, 18–23;
13.
LiuJ, HuW, HeL, YeM, LiY. (2004) Effects of lycorine on HL-60 cells via arresting cell cycle and inducing apoptosis. FEBS letters, 578, 245–250;
14.
LiuJ, LiY, TangLJ, ZhangGP, HuWX. (2007) Treatment of lycorine on SCID mice model with human APL cells. Biomedicine & Pharmacotherapy, 61, 229–234;
15.
LiS, ChenC, ZhangH, GuoH, WangH, WangL, ZhangX, HuaS, YuJ, XiaoP, LiY, LiuJ, TangL, ShiY, RenW, HuW. (2007) Apoptosis induced by lycorine in KM3 cells is associated with the G0/G1 cell cycle arrest. Oncology Reports, 17, 377–384.
16.
McNultyJ, NairJJ, BastidaJ, PandeyS, GriffinC. (2009) Structure-activity studies on the lycorine pharmacophore: a potent inducer of apoptosis in human leukemia cells. Phytochemistry, 70, 913–919.
KornienkoA, EvidenteA, (2008) Chemistry, biology and medicinal potential of narciclasine and its congeners. Chemical Reviews, 108, 1982–2014.
19.
McNultyJ, MaoJ, GibeR, MoR, WolfS, PettitGR, HeraldDL, BoydMR. (2001) Studies directed toward the refinement of the pancratistatin cytotoxic pharmacophore. Bioorganic & Medicinal Chemistry Letters, 11, 169–172;
20.
HudlickyT, RinnerU, GonzalesD, AkgunH, SchillingS, SiengalewiczP, MartinotTA, PettitGR. (2002) Total synthesis and biological evaluation of Amaryllidaceae alkaloids: narciclasine, ent-7-deoxypancratistatin, regioisomer of 7-deoxypancratistatin, 10b-epi-deoxypancra-tistatin, and truncated derivatives. Journal of Organic Chemistry, 67, 8726–8743;
21.
RinnerU, HillebrennerHL, AdamsDR, HudlickyT, PettitGR (2004) Synthesis and biological activity of some structural modifications of pancratistatin. Bioorganic & Medicinal Chemistry Letters, 14, 2911–2915;
22.
McNultyJ, LarichevV, PandeyS. (2005) A synthesis of 3-deoxydihydro-lycoricidine: Refinement of a structurally minimum pancratistatin pharmacophore. Bioorganic & Medicinal Chemistry Letters, 15, 5315–5318;
23.
McNultyJ, NairJJ, GriffinC, PandeyS. (2008) Synthesis and biological evaluation of fully functionalized seco-pancratistatin analogues. Journal of Natural Products, 71, 357–363.
24.
KekreN, GriffinC, McNultyJ, PandeyS. (2005) Pancratistatin causes early activation of caspase-3 and flipping of phosphatidyl serine followed by rapid apoptosis specifically in human lymphoma cells. Cancer Chemotherapy and Pharmacology, 10, 619–630;
25.
McLachlanA, KekreN, McNultyJ, PandeyS. (2005) Pancratistatin: A natural anticancer compound that targets mitochondria specifically in cancer cells to induce apoptosis. Apoptosis, 10, 619–630.
26.
NelsonDR, KoymansL, KamatakiT, StegemanJJ, FeyereisenR, WaxmanDJ, WatermanMR, GotohO, CoonMJ, EstabrookRW, GunsalusIC, NebertDW. (1996) P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics, 6, 1–42.
27.
GuengerichFP. (2001) Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chemical Research in Toxicology, 14, 611–650.
28.
RendicS, Di CarloFJ. (1997) Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metabolism Reviews, 29, 413–580.
McNultyJ, NairJJ, SinghM, CrankshawDJ, HollowayAC. (2009) Structure-activity studies on seco-pancratistatin analogs: potent inhibitors of human cytochrome P450 3A4. Bioorganic & Medicinal Chemistry Letters, 19, 5607–5612;
31.
McNultyJ, NairJJ, SinghM, CrankshawDJ, HollowayAC. (2010) Potent and selective inhibition of human cytochrome P450 3A4 by seco-pancratistatin structural analogs. Bioorganic & Medicinal Chemistry Letters, 20, 2335–2339.
32.
PettitGR, MelodyN, HeraldDL. (2001) Antineoplastic agents. 450. Synthesis of (+)-pancratistatin from (+)-narciclasine as relay. Journal of Organic Chemistry, 66, 2583–2587;
33.
CollinsJ, DrouinM, SunX, RinnerU, HudlickyT (2008) Total synthesis of 7-deoxypancratistatin-1-carboxaldehyde and carboxylic acid via solvent-free intramolecular aziridine opening: phenanthrene to phenanthridone cyclization strategy. Organic Letters, 10, 361–364.
